Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Takakura

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Obstetrics & Gynecology and Reproductive Biology: X|February 13, 2026
Impact of obesity on perioperative outcomes in robot-assisted surgery for endometrial cancer: A single-center study of 119 casesYasushi Iida, Miwako Shimazaki, Ayane Kosuge, et al.
Japanese Journal of Clinical Oncology|September 29, 2016
Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factorsToshiyuki Seki, Hiroshi Tanabe, Chie Nagata, et al.
The Journal of Obstetrics and Gynaecology Research|May 30, 2012
Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapyShiro Kunito, Satoshi Takakura, Chie Nagata, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2014
Impact of surgical staging in stage I clear cell adenocarcinoma of the ovaryKayo Suzuki, Satoshi Takakura, Motoaki Saito, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Cyclin D1 predicts the prognosis of advanced serous ovarian cancerTomoko Hashimoto, Nozomu Yanaihara, Aikou Okamoto, et al.
International Journal of Oncology|March 27, 2012
Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinomaYasushi Iida, Katsuhiko Aoki, Tadashi Asakura, et al.
International Surgery|December 7, 2007
Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after initial surgery for ovarian clear cell adenocarcinomaSatoshi Takakura, Motoaki Saito, Kazu Ueda, et al.
International Journal of Oncology|July 4, 2012
Cytokine gene expression signature in ovarian clear cell carcinomaNozomu Yanaihara, Michael S Anglesio, Kazunori Ochiai, et al.
Archives of Gynecology and Obstetrics|September 4, 2014
Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancerMotoaki Saitou, Yasushi Iida, Hiromi Komazaki, et al.
Oncology Reports|May 10, 2007
Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancerMiho Takao, Aikou Okamoto, Takashi Nikaido, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Obstetrics & Gynecology and Reproductive Biology: X|February 13, 2026
Impact of obesity on perioperative outcomes in robot-assisted surgery for endometrial cancer: A single-center study of 119 casesYasushi Iida, Miwako Shimazaki, Ayane Kosuge, et al.
Japanese Journal of Clinical Oncology|September 29, 2016
Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factorsToshiyuki Seki, Hiroshi Tanabe, Chie Nagata, et al.
The Journal of Obstetrics and Gynaecology Research|May 30, 2012
Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapyShiro Kunito, Satoshi Takakura, Chie Nagata, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2014
Impact of surgical staging in stage I clear cell adenocarcinoma of the ovaryKayo Suzuki, Satoshi Takakura, Motoaki Saito, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Cyclin D1 predicts the prognosis of advanced serous ovarian cancerTomoko Hashimoto, Nozomu Yanaihara, Aikou Okamoto, et al.
International Journal of Oncology|March 27, 2012
Hypoxia promotes glycogen synthesis and accumulation in human ovarian clear cell carcinomaYasushi Iida, Katsuhiko Aoki, Tadashi Asakura, et al.
International Surgery|December 7, 2007
Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after initial surgery for ovarian clear cell adenocarcinomaSatoshi Takakura, Motoaki Saito, Kazu Ueda, et al.
International Journal of Oncology|July 4, 2012
Cytokine gene expression signature in ovarian clear cell carcinomaNozomu Yanaihara, Michael S Anglesio, Kazunori Ochiai, et al.
Archives of Gynecology and Obstetrics|September 4, 2014
Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancerMotoaki Saitou, Yasushi Iida, Hiromi Komazaki, et al.
Oncology Reports|May 10, 2007
Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancerMiho Takao, Aikou Okamoto, Takashi Nikaido, et al.
Pageof 4